CD3+ T cells constituted on average 49.5% in adenocarcinoma and 41.1% in squamous cell carcinoma of all tumor-infiltrating CD45+ leukocytes (Figure 3A). The gene discussed is PTPRC; the disease is squamous cell carcinoma.